Humira 40 MG/0.8 ML syringes
Ended Awarded
- Contract number
- SPE2DR26F4YYR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,962
Award facts
- Contract value 100% obligated
- $14,962.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,962.42 to AmerisourceBergen Drug Corp for the supply of HUMIRA 40 mg/0.8 ml syringes. This firm fixed-price contract, awarded on November 18, 2025, with an ultimate completion date of November 19, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026 that supports pharmaceutical supply needs across the Department of Defense and affiliated federal healthcare systems worldwide.
As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's portfolio of federal contract awards demonstrates its capability to meet competitive procurement requirements and deliver diverse pharmaceutical products to support military healthcare programs globally. This specific delivery order for HUMIRA, a widely used biologic immunosuppressant medication, falls within the company's established expertise in supplying specialty medications and injectable pharmaceutical products to the Defense Health Agency and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DR26F4YYR?
SPE2DR26F4YYR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26F4YYR worth?
The government has obligated $14,962 on SPE2DR26F4YYR.
Is contract SPE2DR26F4YYR an order under another contract?
Yes. SPE2DR26F4YYR is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4YYR competed?
The extent of competition for SPE2DR26F4YYR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award